Virus Filtration Market - 2023-2031
The Virus Filtration Market was valued at US$ 4.71 billion in 2023 and is anticipated to reach US$ 11.51 billion by 2031, at a CAGR of 0.122 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Virus Filtration Market.
This report delivers a comprehensive overview of the Virus Filtration Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Virus Filtration Market. The Virus Filtration Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.
Virus Filtration Market Scope:
By Product
This report delivers a comprehensive overview of the Virus Filtration Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Virus Filtration Market. The Virus Filtration Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Virus Filtration Market.
This report delivers a comprehensive overview of the Virus Filtration Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Virus Filtration Market. The Virus Filtration Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.
Virus Filtration Market Scope:
By Product
- Consumables
- Instruments
- Services
- Others
- Biological
- Medical Devices
- Water Purification
- Air Purification
- Other
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutes
- Other
- Asahi Kasei Medical Co., Ltd.
- Merck KgaA
- Sartorius Group
- Agilitech
- Cytiva
- Stellar Scientific
- Cygnus Technologies
This report delivers a comprehensive overview of the Virus Filtration Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Virus Filtration Market. The Virus Filtration Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Research and Development
4.1.2. Restraints
4.1.2.1. High Costs of Virus Filtration Systems
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. BY PRODUCT
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
6.1.2. Market Attractiveness Index, By Product
6.2. Consumables*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Kits and Reagents
6.2.4. Others
6.3. Instruments
6.3.1. Filtration Systems
6.3.2. Chromatography Systems
6.3.3. Others
6.4. Services
6.5. Others
7. BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Biological*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Vaccines and Therapeutics
7.2.4. Blood and Blood Products
7.2.5. Cellular and Gene Therapy Products
7.2.6. Tissue and Tissue Products
7.2.7. Other
7.3. Medical Devices
7.4. Water Purification
7.5. Air Purification
7.6. Other
8. BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Pharmaceutical and Biotechnology Companies*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Contract Research Organizations (CROs)
8.4. Academic Research Institutes
8.5. Other
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.3.1. The U.S.
9.2.3.2. Canada
9.2.3.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.4.1. Germany
9.3.4.2. UK
9.3.4.3. France
9.3.4.4. Italy
9.3.4.5. Spain
9.3.4.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.4.1. Brazil
9.4.4.2. Argentina
9.4.4.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.4.1. China
9.5.4.2. India
9.5.4.3. Japan
9.5.4.4. South Korea
9.5.4.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. COMPANY PROFILES
11.1. Asahi Kasei Medical Co., Ltd.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Merck KgaA
11.3. Sartorius Group
11.4. Agilitech
11.5. Cytiva
11.6. Stellar Scientific
11.7. Cygnus Technologies (*LIST NOT EXHAUSTIVE)
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Research and Development
4.1.2. Restraints
4.1.2.1. High Costs of Virus Filtration Systems
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. BY PRODUCT
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
6.1.2. Market Attractiveness Index, By Product
6.2. Consumables*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Kits and Reagents
6.2.4. Others
6.3. Instruments
6.3.1. Filtration Systems
6.3.2. Chromatography Systems
6.3.3. Others
6.4. Services
6.5. Others
7. BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Biological*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Vaccines and Therapeutics
7.2.4. Blood and Blood Products
7.2.5. Cellular and Gene Therapy Products
7.2.6. Tissue and Tissue Products
7.2.7. Other
7.3. Medical Devices
7.4. Water Purification
7.5. Air Purification
7.6. Other
8. BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Pharmaceutical and Biotechnology Companies*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Contract Research Organizations (CROs)
8.4. Academic Research Institutes
8.5. Other
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.3.1. The U.S.
9.2.3.2. Canada
9.2.3.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.4.1. Germany
9.3.4.2. UK
9.3.4.3. France
9.3.4.4. Italy
9.3.4.5. Spain
9.3.4.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.4.1. Brazil
9.4.4.2. Argentina
9.4.4.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.4.1. China
9.5.4.2. India
9.5.4.3. Japan
9.5.4.4. South Korea
9.5.4.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. COMPANY PROFILES
11.1. Asahi Kasei Medical Co., Ltd.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Merck KgaA
11.3. Sartorius Group
11.4. Agilitech
11.5. Cytiva
11.6. Stellar Scientific
11.7. Cygnus Technologies (*LIST NOT EXHAUSTIVE)
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
